# Pilot Study of Metformin for Patients With Fanconi Anemia

> **NCT03398824** · PHASE2 · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 15 (actual)

## Conditions studied

- Fanconi Anemia

## Interventions

- **DRUG:** metformin HCl

## Key facts

- **NCT ID:** NCT03398824
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-29
- **Primary completion:** 2020-10-09
- **Final completion:** 2020-10-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03398824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03398824, "Pilot Study of Metformin for Patients With Fanconi Anemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03398824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*